Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

News

Article

May 27, 2025

Daily Derm Times: May 27, 2025

Author(s):

Emma Andrus, Editor

Key Takeaways

Chronic hand eczema lacks FDA-approved treatments, significantly impacting patients' quality of life and necessitating improved therapeutic options.
Nemolizumab's approval for atopic dermatitis follows positive outcomes from the ARCADIA studies, marking a significant advancement in treatment.
Dermalyser, an AI-powered tool for melanoma detection, enhances diagnostic accuracy and has secured CE Mark approval in Europe.
Microneedling demonstrates superior efficacy over microinjections in PRP therapy for melasma, improving patient outcomes and satisfaction.
Amanda Caldwell, MSN, APRN-C, focuses on accessibility and education as the new president of the Society for Dermatology Nurse Practitioners.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

POLL: Are You Seeing the Effects of Federal Research Changes?

Answer our poll below.

The Complex Clinical Landscape of Chronic Hand Eczema

Christopher G. Bunick, MD, PhD, presents the significant challenges of CHE due to a lack of FDA-approved treatments, impacting patients' quality of life and requiring better therapeutic options.

Road to RAD: Nemolizumab for AD

Jonathan Silverberg, MD, PhD, MPH, discusses the results of the recent ARCADIA studies, which ultimately led to the approval of nemolizumab for atopic dermatitis.

Dermalyser Secures CE Mark in Europe for AI-Powered Melanoma Detection Tool

AI Medical Technology launches Dermalyser, an AI tool for melanoma diagnosis, enhancing detection accuracy and skin cancer care in Europe.

Microneedling Outperforms Injections in Melasma PRP Study

Microneedling proves more effective than microinjections for PRP therapy in treating melasma, enhancing patient outcomes and satisfaction.

From Patient to President: Amanda Caldwell, MSN, APRN-C, And Her Journey with SDNP

Amanda Caldwell, MSN, APRN-C, is promoting accessibility, education, and relatability as the newly inducted president of the Society for Dermatology Nurse Practitioners.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!